“CLINICAL SIGNIFICANCE OF SERUM PROSTATE SPECIFIC ANTIGEN IN PROSTATE CANCER PATIENTS AND ITS RELATIONSHIP WITH HYPERCHOLESTEROLEMIA”, rjnmsr, vol. 4, no. 5, pp. 619–631, Jun. 2026, doi: 10.63075/8ca2tj21.